1. IgG4-Related Sclerosing Cholangitis

   • Akash Singh
   • Virendra Singh

   Autoimmune, Cholestatic, and Biliary Diseases (S Gordon and CL Bowlus, Section Editors) 20 July 2020 Pages: 139 - 146

   

2. Hemodynamic and Systemic Effects of Albumin in Patients with Advanced Liver Disease

   • Manuel Tufoni
   • Maurizio Baldassarre
   • Paolo Caraceni

   Management of the Cirrhotic Patient (A Cardenas and P Tandon, Section Editors) Open access 01 July 2020 Pages: 147 - 158

   

3. Lessons Learned from Faecal Microbiota Transplantation in Cirrhosis

   • Grace B. Hatton
   • Shaolu Ran
   • Debbie L. Shawcross

   Management of the Cirrhotic Patient (A Cardenas and P Tandon, Section Editors) Open access 24 June 2020 Pages: 159 - 167

   

4. Early Transplantation in Acute on Chronic Liver Failure: Who and When

   • Nadim Mahmud
   • Ruben Hernaez
   • Vinay Sundaram

   Management of the Cirrhotic Patient (A Cardenas and P Tandon, Section Editors) 18 June 2020 Pages: 168 - 173

   

5. Hepatopulmonary Syndrome and Portopulmonary Hypertension: Current Status and Implications for Liver Transplantation

   • Kelley Weinfurtner
   • Kimberly Forde

   Management of the Cirrhotic Patient (A Cardenas and P Tandon, Section Editors) 11 July 2020 Pages: 174 - 185

   

6. Non-selective Beta-Blockers in Decompensated Cirrhosis

   • Annsa C. Huang
   • James M. Gardner
   • Bilal Hameed

   Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors) 01 July 2020 Pages: 186 - 196

   

7. Budd-Chiari Syndrome: Anticoagulation, TIPS, or Transplant

   • Marta Magaz
   • Guillem Soy
   • Juan Carlos García-Pagán

   Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors) 27 June 2020 Pages: 197 - 202

   

8. Selection for Liver Transplantation: Indications and Evaluation

   • Nadim Mahmud

   Management of the Cirrhotic Patient (A Cardenas and P Tandon, Section Editors) 19 June 2020 Pages: 203 - 212

9. Esophageal Varices: Primary Prophylaxis and Prevention and Management of Rebleeding

   • Mengfei Liu
   • Moira Hilscher
   • Patrick S. Kamath

   Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors) 30 June 2020 Pages: 213 - 225

   

10. Portal Hypertensive Ascites: Current Status

    • Savio John
    • Lawrence S. Friedman

    Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors) 24 June 2020 Pages: 226 - 234

    

11. Targeting Viral cccDNA for Cure of Chronic Hepatitis B

    • Gaëtan Ligat
    • Kaku Goto
    • Thomas F. Baumert

    Hepatitis B (JK Lim, Section Editor) Open access 10 July 2020 Pages: 235 - 244

    

12. Point of Care Diagnostic Testing for Hepatitis B Virus

    • Kathy Jackson
    • Robert G. Gish

    Hepatitis B (JK Lim, Section Editor) 22 June 2020 Pages: 245 - 253

    

13. Hepatitis B Core Antibody: Role in Clinical Practice in 2020

    • Robert G. Gish
    • Syed Abdul Basit
    • Ulrike Protzer

    Hepatitis B (JK Lim, Section Editor) Open access 11 July 2020 Pages: 254 - 265

    

14. Prevention and Management of HBV in Organ Transplantation

    • Stela Celaj
    • Josh Levitsky

    Hepatitis B (JK Lim, Section Editor) 18 July 2020 Pages: 266 - 275

    

15. Management of Acute Hepatitis B Virus Infection

    • Mitchell L. Shiffman

    Hepatitis B (JK Lim, Section Editor) 21 July 2020 Pages: 276 - 284

    

16. Assessment of HCC Risk in Patients with Chronic HBV (REACH, PAGE-B, and Beyond)

    • Terry Cheuk-Fung Yip
    • Lilian Yan Liang
    • Grace Lai-Hung Wong

    Hepatitis B (JK Lim, Section Editor) 19 June 2020 Pages: 285 - 292

    

17. Role of Core/Capsid Inhibitors in Functional Cure Strategies for Chronic Hepatitis B

    • Rex Wan-Hin Hui
    • Lung-Yi Mak
    • Man-Fung Yuen

    Hepatitis B (JK Lim, Section Editor) 22 June 2020 Pages: 293 - 301

    

18. Metabolic Targets in Nonalcoholic Steatohepatitis: Treating the Disease at the Metabolic Root

    • Pankaj Aggarwal
    • Tamneet Singh
    • Naim Alkhouri

    Fatty Liver Disease (V Ajmera, Section Editor) 05 August 2020 Pages: 302 - 314

    

19. Cardiovascular Disease in Nonalcoholic Steatohepatitis: Screening and Management

    • Hersh Shroff
    • Lisa B. VanWagner

    Fatty Liver Disease (V Ajmera, Section Editor) 29 June 2020 Pages: 315 - 326